Michael A. Sherman - Jul 25, 2022 Form 4/A - Amendment Insider Report for CHIMERIX INC (CMRX)

Role: Chief Executive Officer, Director
Signature: /s/ Michael Alrutz, Attorney-in-fact
Stock symbol: CMRX
Transactions as of: Jul 25, 2022
Transactions value $: $209,000
Form type: 4/A - Amendment
Date filed: 7/27/2022, 01:46 PM
Date Of Original Report: Jul 26, 2022
Previous filing: Jun 3, 2022
Next filing: Jan 19, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CMRX	Common Stock	Options Exercise	$209K	+100K	+394.26%	$2.09	125K	Jul 25, 2022	Direct	F1
holding	CMRX	Common Stock						103K	Jul 25, 2022	By Sherman Investors LLC	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CMRX	Employee Stock Option (Right to Buy)	Options Exercise	$0	-100K	-8%	$0.00	1.15M	Jul 25, 2022	Common Stock	100K	$2.09	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 5,147 shares acquired under the Issuer's Employee Stock Purchase Plan (the "ESPP") on September 10, 2020, 5,147 shares acquired under the Issuer's ESPP on March 10, 2021, 5,147 shares acquired under the Issuer's ESPP on September 10, 2021 and 5,233 shares acquired under the Issuer's ESPP on March 10, 2022.
F2	A Form 4 filed on 07/26/2022, mistakenly did not report indirect holdings held by Sherman Investors LLC.
F3	One-fourth of the shares subject to the stock option vest and become exercisable on the first anniversary of the date of grant, and the remaining shares vest in 36 equal monthly installments thereafter.